{"limit": 20, "offset": 0, "total": 20, "items": [{"id": "uuid:49164e00-fd19-11ee-873f-57b99ea66a06", "category": "biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation", "subject": "CHEBI:38777", "original_subject": "MESH:D001384", "subject_namespace": "CHEBI", "subject_category": "biolink:MolecularEntity", "subject_closure": ["CHEBI:72695", "CHEBI:33285", "CHEBI:50860", "BFO:0000040", "CHEBI:33661", "CHEBI:25367", "CHEBI:33670", "CHEBI:33302", "CHEBI:23367", "CHEBI:33582", "CHEBI:38101", "CHEBI:25693", "CHEBI:38777", "BFO:0000002", "CHEBI:5686", "BFO:0000004", "BFO:0000001", "CHEBI:24532", "CHEBI:24431", "CHEBI:51143", "CHEBI:36357", "CHEBI:33675", "CHEBI:35352", "CHEBI:33595", "CHEBI:33832", "CHEBI:33579"], "subject_label": "azetidines", "subject_closure_label": ["heteromonocyclic compound", "continuant", "chemical entity", "nitrogen molecular entity", "monocyclic compound", "independent continuant", "entity", "cyclic compound", "organic cyclic compound", "main group molecular entity", "organic molecular entity", "organic heteromonocyclic compound", "pnictogen molecular entity", "carbon group molecular entity", "molecular entity", "azetidines", "organic molecule", "heteroorganic entity", "p-block molecular entity", "material entity", "organonitrogen heterocyclic compound", "heterocyclic compound", "molecule", "organonitrogen compound", "organic heterocyclic compound", "polyatomic entity"], "subject_taxon": null, "subject_taxon_label": null, "predicate": "biolink:treats_or_applied_or_studied_to_treat", "object": "MONDO:0006732", "original_object": "MESH:D004409", "object_namespace": "MONDO", "object_category": "biolink:Disease", "object_closure": ["OGMS:0000031", "BFO:0000016", "BFO:0000001", "MONDO:0006732", "BFO:0000002", "MONDO:0005071", "BFO:0000017", "BFO:0000020", "MONDO:0700096", "MONDO:0000001"], "object_label": "drug-induced dyskinesia", "object_closure_label": ["disease", "drug-induced dyskinesia", "disposition", "nervous system disorder", "continuant", "disease", "specifically dependent continuant", "realizable entity", "human disease", "entity"], "object_taxon": null, "object_taxon_label": null, "primary_knowledge_source": "infores:ctd", "aggregator_knowledge_source": ["infores:monarchinitiative"], "negated": null, "pathway": null, "evidence_count": 1, "knowledge_level": "knowledge_assertion", "agent_type": "manual_agent", "has_evidence": [], "has_evidence_links": [], "has_count": null, "has_total": null, "has_percentage": null, "has_quotient": null, "grouping_key": "CHEBI:38777||biolink:treats_or_applied_or_studied_to_treat|MONDO:0006732", "provided_by": "ctd_chemical_to_disease_edges", "provided_by_link": {"id": "ctd_chemical_to_disease", "url": "https://monarch-initiative.github.io/monarch-ingest/Sources/ctd/#chemical_to_disease"}, "publications": ["PMID:16124929"], "publications_links": [{"id": "PMID:16124929", "url": "http://identifiers.org/pubmed/16124929"}], "frequency_qualifier": null, "onset_qualifier": null, "sex_qualifier": null, "stage_qualifier": null, "qualifiers": [], "qualifiers_label": null, "qualifiers_namespace": null, "qualifiers_category": null, "qualifiers_closure": [], "qualifiers_closure_label": [], "qualifier": [], "qualifier_label": null, "qualifier_namespace": null, "qualifier_category": null, "qualifier_closure": [], "qualifier_closure_label": [], "frequency_qualifier_label": null, "frequency_qualifier_namespace": null, "frequency_qualifier_category": null, "frequency_qualifier_closure": [], "frequency_qualifier_closure_label": [], "onset_qualifier_label": null, "onset_qualifier_namespace": null, "onset_qualifier_category": null, "onset_qualifier_closure": [], "onset_qualifier_closure_label": [], "sex_qualifier_label": null, "sex_qualifier_namespace": null, "sex_qualifier_category": null, "sex_qualifier_closure": [], "sex_qualifier_closure_label": [], "stage_qualifier_label": null, "stage_qualifier_namespace": null, "stage_qualifier_category": null, "stage_qualifier_closure": [], "stage_qualifier_closure_label": []}, {"id": "uuid:4b21b693-fd19-11ee-873f-57b99ea66a06", "category": "biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation", "subject": "CHEBI:3647", "original_subject": "MESH:D002746", "subject_namespace": "CHEBI", "subject_category": "biolink:MolecularEntity", "subject_closure": ["CHEBI:37577", "CHEBI:72695", "CHEBI:33285", "CHEBI:51958", "CHEBI:33671", "CHEBI:50860", "CHEBI:25367", "CHEBI:23117", "CHEBI:33302", "CHEBI:38093", "CHEBI:50047", "CHEBI:33582", "CHEBI:38166", "CHEBI:37578", "CHEBI:26979", "CHEBI:36683", "BFO:0000040", "CHEBI:24471", "CHEBI:32876", "CHEBI:36688", "CHEBI:51959", "CHEBI:5686", "BFO:0000004", "BFO:0000001", "CHEBI:50996", "CHEBI:33635", "CHEBI:24532", "CHEBI:24431", "CHEBI:51143", "CHEBI:36357", "CHEBI:32952", "CHEBI:33675", "BFO:0000002", "CHEBI:17792", "CHEBI:3647", "CHEBI:23367", "CHEBI:35352", "CHEBI:33595", "CHEBI:33832", "CHEBI:33579"], "subject_label": "chlorpromazine", "subject_closure_label": ["chlorine molecular entity", "organochlorine compound", "chemical entity", "nitrogen molecular entity", "organic polycyclic compound", "independent continuant", "entity", "cyclic compound", "organic cyclic compound", "main group molecular entity", "amine", "heteropolycyclic compound", "organic molecular entity", "continuant", "organohalogen compound", "halide", "pnictogen molecular entity", "carbon group molecular entity", "phenothiazines", "organic amino compound", "organic heterotricyclic compound", "heterotricyclic compound", "material entity", "organic molecule", "heteroorganic entity", "p-block molecular entity", "organic heteropolycyclic compound", "chlorpromazine", "molecular entity", "heteroatomic molecular entity", "halogen molecular entity", "tertiary amine", "organic tricyclic compound", "heterocyclic compound", "molecule", "organonitrogen compound", "tertiary amino compound", "polycyclic compound", "organic heterocyclic compound", "polyatomic entity"], "subject_taxon": null, "subject_taxon_label": null, "predicate": "biolink:treats_or_applied_or_studied_to_treat", "object": "MONDO:0006732", "original_object": "MESH:D004409", "object_namespace": "MONDO", "object_category": "biolink:Disease", "object_closure": ["OGMS:0000031", "BFO:0000016", "BFO:0000001", "MONDO:0006732", "BFO:0000002", "MONDO:0005071", "BFO:0000017", "BFO:0000020", "MONDO:0700096", "MONDO:0000001"], "object_label": "drug-induced dyskinesia", "object_closure_label": ["disease", "drug-induced dyskinesia", "disposition", "nervous system disorder", "continuant", "disease", "specifically dependent continuant", "realizable entity", "human disease", "entity"], "object_taxon": null, "object_taxon_label": null, "primary_knowledge_source": "infores:ctd", "aggregator_knowledge_source": ["infores:monarchinitiative"], "negated": null, "pathway": null, "evidence_count": 2, "knowledge_level": "knowledge_assertion", "agent_type": "manual_agent", "has_evidence": [], "has_evidence_links": [], "has_count": null, "has_total": null, "has_percentage": null, "has_quotient": null, "grouping_key": "CHEBI:3647||biolink:treats_or_applied_or_studied_to_treat|MONDO:0006732", "provided_by": "ctd_chemical_to_disease_edges", "provided_by_link": {"id": "ctd_chemical_to_disease", "url": "https://monarch-initiative.github.io/monarch-ingest/Sources/ctd/#chemical_to_disease"}, "publications": ["PMID:1350058", "PMID:5781950"], "publications_links": [{"id": "PMID:1350058", "url": "http://identifiers.org/pubmed/1350058"}, {"id": "PMID:5781950", "url": "http://identifiers.org/pubmed/5781950"}], "frequency_qualifier": null, "onset_qualifier": null, "sex_qualifier": null, "stage_qualifier": null, "qualifiers": [], "qualifiers_label": null, "qualifiers_namespace": null, "qualifiers_category": null, "qualifiers_closure": [], "qualifiers_closure_label": [], "qualifier": [], "qualifier_label": null, "qualifier_namespace": null, "qualifier_category": null, "qualifier_closure": [], "qualifier_closure_label": [], "frequency_qualifier_label": null, "frequency_qualifier_namespace": null, "frequency_qualifier_category": null, "frequency_qualifier_closure": [], "frequency_qualifier_closure_label": [], "onset_qualifier_label": null, "onset_qualifier_namespace": null, "onset_qualifier_category": null, "onset_qualifier_closure": [], "onset_qualifier_closure_label": [], "sex_qualifier_label": null, "sex_qualifier_namespace": null, "sex_qualifier_category": null, "sex_qualifier_closure": [], "sex_qualifier_closure_label": [], "stage_qualifier_label": null, "stage_qualifier_namespace": null, "stage_qualifier_category": null, "stage_qualifier_closure": [], "stage_qualifier_closure_label": []}, {"id": "uuid:4c2f75cc-fd19-11ee-873f-57b99ea66a06", "category": "biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation", "subject": "CHEBI:3766", "original_subject": "MESH:D003024", "subject_namespace": "CHEBI", "subject_category": "biolink:MolecularEntity", "subject_closure": ["CHEBI:37577", "CHEBI:72695", "CHEBI:33285", "CHEBI:33671", "CHEBI:50860", "BFO:0000040", "CHEBI:33661", "CHEBI:25367", "CHEBI:33670", "CHEBI:23117", "CHEBI:33302", "CHEBI:50047", "CHEBI:33860", "CHEBI:46920", "CHEBI:33582", "CHEBI:38166", "CHEBI:38101", "CHEBI:37578", "CHEBI:36683", "CHEBI:22720", "CHEBI:25693", "CHEBI:33659", "CHEBI:24471", "CHEBI:46848", "BFO:0000002", "CHEBI:5686", "CHEBI:33655", "BFO:0000004", "BFO:0000001", "CHEBI:3766", "CHEBI:50996", "CHEBI:33635", "CHEBI:24532", "CHEBI:24431", "CHEBI:51143", "CHEBI:36357", "CHEBI:26144", "CHEBI:33675", "CHEBI:46845", "CHEBI:17792", "CHEBI:23367", "CHEBI:35352", "CHEBI:33595", "CHEBI:33832", "CHEBI:33579"], "subject_label": "clozapine", "subject_closure_label": ["heteromonocyclic compound", "chlorine molecular entity", "organochlorine compound", "benzodiazepine", "continuant", "chemical entity", "nitrogen molecular entity", "monocyclic compound", "independent continuant", "entity", "cyclic compound", "organic cyclic compound", "main group molecular entity", "heteropolycyclic compound", "organic molecular entity", "organohalogen compound", "organic heteromonocyclic compound", "organic aromatic compound", "halide", "aromatic amine", "pnictogen molecular entity", "carbon group molecular entity", "organic amino compound", "N-arylpiperazine", "organic molecule", "heteroorganic entity", "p-block molecular entity", "N-alkylpiperazine", "material entity", "organic heteropolycyclic compound", "organonitrogen heterocyclic compound", "molecular entity", "heteroatomic molecular entity", "aromatic compound", "halogen molecular entity", "N-methylpiperazine", "heterocyclic compound", "molecule", "organonitrogen compound", "clozapine", "tertiary amino compound", "polycyclic compound", "organic heterocyclic compound", "polyatomic entity", "piperazines"], "subject_taxon": null, "subject_taxon_label": null, "predicate": "biolink:treats_or_applied_or_studied_to_treat", "object": "MONDO:0006732", "original_object": "MESH:D004409", "object_namespace": "MONDO", "object_category": "biolink:Disease", "object_closure": ["OGMS:0000031", "BFO:0000016", "BFO:0000001", "MONDO:0006732", "BFO:0000002", "MONDO:0005071", "BFO:0000017", "BFO:0000020", "MONDO:0700096", "MONDO:0000001"], "object_label": "drug-induced dyskinesia", "object_closure_label": ["disease", "drug-induced dyskinesia", "disposition", "nervous system disorder", "continuant", "disease", "specifically dependent continuant", "realizable entity", "human disease", "entity"], "object_taxon": null, "object_taxon_label": null, "primary_knowledge_source": "infores:ctd", "aggregator_knowledge_source": ["infores:monarchinitiative"], "negated": null, "pathway": null, "evidence_count": 6, "knowledge_level": "knowledge_assertion", "agent_type": "manual_agent", "has_evidence": [], "has_evidence_links": [], "has_count": null, "has_total": null, "has_percentage": null, "has_quotient": null, "grouping_key": "CHEBI:3766||biolink:treats_or_applied_or_studied_to_treat|MONDO:0006732", "provided_by": "ctd_chemical_to_disease_edges", "provided_by_link": {"id": "ctd_chemical_to_disease", "url": "https://monarch-initiative.github.io/monarch-ingest/Sources/ctd/#chemical_to_disease"}, "publications": ["PMID:10078726", "PMID:14872017", "PMID:16960862", "PMID:7969207", "PMID:8043043", "PMID:9065543"], "publications_links": [{"id": "PMID:10078726", "url": "http://identifiers.org/pubmed/10078726"}, {"id": "PMID:14872017", "url": "http://identifiers.org/pubmed/14872017"}, {"id": "PMID:16960862", "url": "http://identifiers.org/pubmed/16960862"}, {"id": "PMID:7969207", "url": "http://identifiers.org/pubmed/7969207"}, {"id": "PMID:8043043", "url": "http://identifiers.org/pubmed/8043043"}, {"id": "PMID:9065543", "url": "http://identifiers.org/pubmed/9065543"}], "frequency_qualifier": null, "onset_qualifier": null, "sex_qualifier": null, "stage_qualifier": null, "qualifiers": [], "qualifiers_label": null, "qualifiers_namespace": null, "qualifiers_category": null, "qualifiers_closure": [], "qualifiers_closure_label": [], "qualifier": [], "qualifier_label": null, "qualifier_namespace": null, "qualifier_category": null, "qualifier_closure": [], "qualifier_closure_label": [], "frequency_qualifier_label": null, "frequency_qualifier_namespace": null, "frequency_qualifier_category": null, "frequency_qualifier_closure": [], "frequency_qualifier_closure_label": [], "onset_qualifier_label": null, "onset_qualifier_namespace": null, "onset_qualifier_category": null, "onset_qualifier_closure": [], "onset_qualifier_closure_label": [], "sex_qualifier_label": null, "sex_qualifier_namespace": null, "sex_qualifier_category": null, "sex_qualifier_closure": [], "sex_qualifier_closure_label": [], "stage_qualifier_label": null, "stage_qualifier_namespace": null, "stage_qualifier_category": null, "stage_qualifier_closure": [], "stage_qualifier_closure_label": []}, {"id": "uuid:4c2f7726-fd19-11ee-873f-57b99ea66a06", "category": "biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation", "subject": "CHEBI:16827", "original_subject": "MESH:D003345", "subject_namespace": "CHEBI", "subject_category": "biolink:MolecularEntity", "subject_closure": ["CHEBI:3992", "CHEBI:37577", "CHEBI:72695", "CHEBI:33285", "CHEBI:51958", "CHEBI:51689", "CHEBI:139588", "CHEBI:78840", "CHEBI:47788", "CHEBI:30879", "CHEBI:50860", "BFO:0000040", "CHEBI:15734", "CHEBI:52396", "CHEBI:25367", "CHEBI:51721", "CHEBI:61313", "CHEBI:36587", "CHEBI:36699", "CHEBI:36962", "CHEBI:36963", "CHEBI:23367", "CHEBI:35346", "CHEBI:35350", "CHEBI:18059", "CHEBI:16827", "CHEBI:33304", "CHEBI:33582", "CHEBI:139590", "CHEBI:50858", "CHEBI:36841", "CHEBI:33608", "CHEBI:17087", "CHEBI:52395", "CHEBI:36885", "CHEBI:25806", "CHEBI:36586", "CHEBI:35344", "CHEBI:33674", "CHEBI:33635", "CHEBI:26764", "CHEBI:24431", "CHEBI:35789", "BFO:0000004", "CHEBI:36357", "BFO:0000001", "CHEBI:33675", "CHEBI:33822", "BFO:0000002", "CHEBI:24651", "CHEBI:35341", "CHEBI:47909", "CHEBI:24261", "CHEBI:33595", "CHEBI:33832", "CHEBI:33579"], "subject_label": "corticosterone", "subject_closure_label": ["organic oxo compound", "corticosteroid hormone", "hydrogen molecular entity", "chemical entity", "primary alcohol", "alpha-oxyketone", "organic polycyclic compound", "21-hydroxy steroid", "s-block molecular entity", "glucocorticoid", "cyclic compound", "organic cyclic compound", "main group molecular entity", "olefinic compound", "3-oxo steroid", "alcohol", "organic molecular entity", "continuant", "hydroxides", "ketone", "oxyketone", "11-hydroxy steroid", "entity", "alpha-hydroxy ketone", "lipid", "corticosterone", "chalcogen molecular entity", "carbon group molecular entity", "organooxygen compound", "molecular entity", "11beta-hydroxy steroid", "hydroxy steroid", "oxygen molecular entity", "carbonyl compound", "organic molecule", "heteroorganic entity", "alpha,beta-unsaturated ketone", "C21-steroid", "p-block molecular entity", "organic hydroxy compound", "material entity", "primary alpha-hydroxy ketone", "corticosteroid", "steroid", "enone", "cyclic ketone", "heteroatomic molecular entity", "oxo steroid", "20-oxo steroid", "steroid hormone", "molecule", "3-oxo-Delta(4) steroid", "polycyclic compound", "organochalcogen compound", "independent continuant", "polyatomic entity"], "subject_taxon": null, "subject_taxon_label": null, "predicate": "biolink:treats_or_applied_or_studied_to_treat", "object": "MONDO:0006732", "original_object": "MESH:D004409", "object_namespace": "MONDO", "object_category": "biolink:Disease", "object_closure": ["OGMS:0000031", "BFO:0000016", "BFO:0000001", "MONDO:0006732", "BFO:0000002", "MONDO:0005071", "BFO:0000017", "BFO:0000020", "MONDO:0700096", "MONDO:0000001"], "object_label": "drug-induced dyskinesia", "object_closure_label": ["disease", "drug-induced dyskinesia", "disposition", "nervous system disorder", "continuant", "disease", "specifically dependent continuant", "realizable entity", "human disease", "entity"], "object_taxon": null, "object_taxon_label": null, "primary_knowledge_source": "infores:ctd", "aggregator_knowledge_source": ["infores:monarchinitiative"], "negated": null, "pathway": null, "evidence_count": 1, "knowledge_level": "knowledge_assertion", "agent_type": "manual_agent", "has_evidence": [], "has_evidence_links": [], "has_count": null, "has_total": null, "has_percentage": null, "has_quotient": null, "grouping_key": "CHEBI:16827||biolink:treats_or_applied_or_studied_to_treat|MONDO:0006732", "provided_by": "ctd_chemical_to_disease_edges", "provided_by_link": {"id": "ctd_chemical_to_disease", "url": "https://monarch-initiative.github.io/monarch-ingest/Sources/ctd/#chemical_to_disease"}, "publications": ["PMID:18687386"], "publications_links": [{"id": "PMID:18687386", "url": "http://identifiers.org/pubmed/18687386"}], "frequency_qualifier": null, "onset_qualifier": null, "sex_qualifier": null, "stage_qualifier": null, "qualifiers": [], "qualifiers_label": null, "qualifiers_namespace": null, "qualifiers_category": null, "qualifiers_closure": [], "qualifiers_closure_label": [], "qualifier": [], "qualifier_label": null, "qualifier_namespace": null, "qualifier_category": null, "qualifier_closure": [], "qualifier_closure_label": [], "frequency_qualifier_label": null, "frequency_qualifier_namespace": null, "frequency_qualifier_category": null, "frequency_qualifier_closure": [], "frequency_qualifier_closure_label": [], "onset_qualifier_label": null, "onset_qualifier_namespace": null, "onset_qualifier_category": null, "onset_qualifier_closure": [], "onset_qualifier_closure_label": [], "sex_qualifier_label": null, "sex_qualifier_namespace": null, "sex_qualifier_category": null, "sex_qualifier_closure": [], "sex_qualifier_closure_label": [], "stage_qualifier_label": null, "stage_qualifier_namespace": null, "stage_qualifier_category": null, "stage_qualifier_closure": [], "stage_qualifier_closure_label": []}, {"id": "uuid:4cd5c8b0-fd19-11ee-873f-57b99ea66a06", "category": "biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation", "subject": "CHEBI:4031", "original_subject": "MESH:D016572", "subject_namespace": "CHEBI", "subject_category": "biolink:MolecularEntity", "subject_closure": ["CHEBI:33285", "CHEBI:23449", "CHEBI:50860", "BFO:0000040", "CHEBI:16670", "CHEBI:24613", "CHEBI:33302", "CHEBI:36962", "CHEBI:37622", "CHEBI:36963", "CHEBI:23367", "CHEBI:50047", "CHEBI:33304", "CHEBI:33582", "CHEBI:33256", "BFO:0000002", "CHEBI:4031", "CHEBI:25806", "BFO:0000001", "CHEBI:24431", "CHEBI:51143", "CHEBI:32988", "BFO:0000004", "CHEBI:33675", "CHEBI:35352", "CHEBI:33579"], "subject_label": "cyclosporin A", "subject_closure_label": ["chemical entity", "nitrogen molecular entity", "peptide", "homodetic cyclic peptide", "entity", "main group molecular entity", "organic molecular entity", "cyclic peptide", "cyclosporin A", "primary amide", "pnictogen molecular entity", "chalcogen molecular entity", "carbon group molecular entity", "carboxamide", "organooxygen compound", "molecular entity", "organic amino compound", "oxygen molecular entity", "continuant", "heteroorganic entity", "p-block molecular entity", "material entity", "organonitrogen compound", "organochalcogen compound", "amide", "independent continuant"], "subject_taxon": null, "subject_taxon_label": null, "predicate": "biolink:treats_or_applied_or_studied_to_treat", "object": "MONDO:0006732", "original_object": "MESH:D004409", "object_namespace": "MONDO", "object_category": "biolink:Disease", "object_closure": ["OGMS:0000031", "BFO:0000016", "BFO:0000001", "MONDO:0006732", "BFO:0000002", "MONDO:0005071", "BFO:0000017", "BFO:0000020", "MONDO:0700096", "MONDO:0000001"], "object_label": "drug-induced dyskinesia", "object_closure_label": ["disease", "drug-induced dyskinesia", "disposition", "nervous system disorder", "continuant", "disease", "specifically dependent continuant", "realizable entity", "human disease", "entity"], "object_taxon": null, "object_taxon_label": null, "primary_knowledge_source": "infores:ctd", "aggregator_knowledge_source": ["infores:monarchinitiative"], "negated": null, "pathway": null, "evidence_count": 1, "knowledge_level": "knowledge_assertion", "agent_type": "manual_agent", "has_evidence": [], "has_evidence_links": [], "has_count": null, "has_total": null, "has_percentage": null, "has_quotient": null, "grouping_key": "CHEBI:4031||biolink:treats_or_applied_or_studied_to_treat|MONDO:0006732", "provided_by": "ctd_chemical_to_disease_edges", "provided_by_link": {"id": "ctd_chemical_to_disease", "url": "https://monarch-initiative.github.io/monarch-ingest/Sources/ctd/#chemical_to_disease"}, "publications": ["PMID:20448265"], "publications_links": [{"id": "PMID:20448265", "url": "http://identifiers.org/pubmed/20448265"}], "frequency_qualifier": null, "onset_qualifier": null, "sex_qualifier": null, "stage_qualifier": null, "qualifiers": [], "qualifiers_label": null, "qualifiers_namespace": null, "qualifiers_category": null, "qualifiers_closure": [], "qualifiers_closure_label": [], "qualifier": [], "qualifier_label": null, "qualifier_namespace": null, "qualifier_category": null, "qualifier_closure": [], "qualifier_closure_label": [], "frequency_qualifier_label": null, "frequency_qualifier_namespace": null, "frequency_qualifier_category": null, "frequency_qualifier_closure": [], "frequency_qualifier_closure_label": [], "onset_qualifier_label": null, "onset_qualifier_namespace": null, "onset_qualifier_category": null, "onset_qualifier_closure": [], "onset_qualifier_closure_label": [], "sex_qualifier_label": null, "sex_qualifier_namespace": null, "sex_qualifier_category": null, "sex_qualifier_closure": [], "sex_qualifier_closure_label": [], "stage_qualifier_label": null, "stage_qualifier_namespace": null, "stage_qualifier_category": null, "stage_qualifier_closure": [], "stage_qualifier_closure_label": []}, {"id": "uuid:4d85aa0f-fd19-11ee-873f-57b99ea66a06", "category": "biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation", "subject": "CHEBI:15551", "original_subject": "MESH:D015232", "subject_namespace": "CHEBI", "subject_category": "biolink:MolecularEntity", "subject_closure": ["CHEBI:3992", "CHEBI:37577", "CHEBI:72695", "CHEBI:33285", "CHEBI:30879", "CHEBI:50860", "BFO:0000040", "CHEBI:25367", "CHEBI:15551", "CHEBI:36587", "CHEBI:36962", "CHEBI:36963", "CHEBI:18059", "CHEBI:33304", "CHEBI:33582", "CHEBI:33608", "CHEBI:26338", "CHEBI:17087", "CHEBI:23899", "CHEBI:25806", "CHEBI:36586", "CHEBI:26333", "CHEBI:33674", "BFO:0000004", "BFO:0000001", "CHEBI:61697", "CHEBI:24431", "CHEBI:36357", "CHEBI:35681", "CHEBI:33675", "CHEBI:33822", "BFO:0000002", "CHEBI:24651", "CHEBI:23367", "CHEBI:26347", "CHEBI:33579"], "subject_label": "prostaglandin E2", "subject_closure_label": ["organic oxo compound", "hydrogen molecular entity", "chemical entity", "prostaglandin", "s-block molecular entity", "independent continuant", "entity", "prostanoid", "main group molecular entity", "alcohol", "organic molecular entity", "continuant", "hydroxides", "ketone", "lipid", "chalcogen molecular entity", "carbon group molecular entity", "organooxygen compound", "icosanoid", "oxygen molecular entity", "carbonyl compound", "organic molecule", "heteroorganic entity", "p-block molecular entity", "organic hydroxy compound", "material entity", "molecular entity", "cyclic ketone", "heteroatomic molecular entity", "fatty acid derivative", "molecule", "prostaglandin E2", "organochalcogen compound", "prostaglandins E", "polyatomic entity", "secondary alcohol"], "subject_taxon": null, "subject_taxon_label": null, "predicate": "biolink:treats_or_applied_or_studied_to_treat", "object": "MONDO:0006732", "original_object": "MESH:D004409", "object_namespace": "MONDO", "object_category": "biolink:Disease", "object_closure": ["OGMS:0000031", "BFO:0000016", "BFO:0000001", "MONDO:0006732", "BFO:0000002", "MONDO:0005071", "BFO:0000017", "BFO:0000020", "MONDO:0700096", "MONDO:0000001"], "object_label": "drug-induced dyskinesia", "object_closure_label": ["disease", "drug-induced dyskinesia", "disposition", "nervous system disorder", "continuant", "disease", "specifically dependent continuant", "realizable entity", "human disease", "entity"], "object_taxon": null, "object_taxon_label": null, "primary_knowledge_source": "infores:ctd", "aggregator_knowledge_source": ["infores:monarchinitiative"], "negated": null, "pathway": null, "evidence_count": 1, "knowledge_level": "knowledge_assertion", "agent_type": "manual_agent", "has_evidence": [], "has_evidence_links": [], "has_count": null, "has_total": null, "has_percentage": null, "has_quotient": null, "grouping_key": "CHEBI:15551||biolink:treats_or_applied_or_studied_to_treat|MONDO:0006732", "provided_by": "ctd_chemical_to_disease_edges", "provided_by_link": {"id": "ctd_chemical_to_disease", "url": "https://monarch-initiative.github.io/monarch-ingest/Sources/ctd/#chemical_to_disease"}, "publications": ["PMID:3862460"], "publications_links": [{"id": "PMID:3862460", "url": "http://identifiers.org/pubmed/3862460"}], "frequency_qualifier": null, "onset_qualifier": null, "sex_qualifier": null, "stage_qualifier": null, "qualifiers": [], "qualifiers_label": null, "qualifiers_namespace": null, "qualifiers_category": null, "qualifiers_closure": [], "qualifiers_closure_label": [], "qualifier": [], "qualifier_label": null, "qualifier_namespace": null, "qualifier_category": null, "qualifier_closure": [], "qualifier_closure_label": [], "frequency_qualifier_label": null, "frequency_qualifier_namespace": null, "frequency_qualifier_category": null, "frequency_qualifier_closure": [], "frequency_qualifier_closure_label": [], "onset_qualifier_label": null, "onset_qualifier_namespace": null, "onset_qualifier_category": null, "onset_qualifier_closure": [], "onset_qualifier_closure_label": [], "sex_qualifier_label": null, "sex_qualifier_namespace": null, "sex_qualifier_category": null, "sex_qualifier_closure": [], "sex_qualifier_closure_label": [], "stage_qualifier_label": null, "stage_qualifier_namespace": null, "stage_qualifier_category": null, "stage_qualifier_closure": [], "stage_qualifier_closure_label": []}, {"id": "uuid:4e867e37-fd19-11ee-873f-57b99ea66a06", "category": "biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation", "subject": "CHEBI:36005", "original_subject": "MESH:D004281", "subject_namespace": "CHEBI", "subject_category": "biolink:MolecularEntity", "subject_closure": ["CHEBI:37577", "CHEBI:72695", "CHEBI:33285", "CHEBI:78840", "CHEBI:50860", "CHEBI:25367", "CHEBI:36587", "CHEBI:36962", "CHEBI:36963", "CHEBI:23367", "CHEBI:53339", "CHEBI:18059", "CHEBI:33304", "CHEBI:33582", "CHEBI:33608", "BFO:0000040", "BFO:0000002", "CHEBI:24833", "CHEBI:64709", "CHEBI:15904", "CHEBI:33575", "CHEBI:25806", "CHEBI:36586", "CHEBI:25384", "CHEBI:35366", "CHEBI:33674", "BFO:0000001", "CHEBI:24431", "BFO:0000004", "CHEBI:36357", "CHEBI:33675", "CHEBI:132544", "CHEBI:35605", "CHEBI:24651", "CHEBI:36005", "CHEBI:27208", "CHEBI:26208", "CHEBI:33579"], "subject_label": "docosahexaenoic acid", "subject_closure_label": ["organic oxo compound", "hydrogen molecular entity", "chemical entity", "fatty acid", "s-block molecular entity", "entity", "polyunsaturated fatty acid", "main group molecular entity", "olefinic compound", "organic molecular entity", "carbon oxoacid", "hydroxides", "oxoacid", "olefinic fatty acid", "lipid", "chalcogen molecular entity", "carbon group molecular entity", "organooxygen compound", "molecular entity", "oxygen molecular entity", "carbonyl compound", "material entity", "continuant", "organic molecule", "heteroorganic entity", "p-block molecular entity", "fatty acid 22:6", "docosahexaenoic acid", "heteroatomic molecular entity", "organic acid", "long-chain fatty acid", "carboxylic acid", "monocarboxylic acid", "molecule", "unsaturated fatty acid", "organochalcogen compound", "independent continuant", "polyatomic entity"], "subject_taxon": null, "subject_taxon_label": null, "predicate": "biolink:treats_or_applied_or_studied_to_treat", "object": "MONDO:0006732", "original_object": "MESH:D004409", "object_namespace": "MONDO", "object_category": "biolink:Disease", "object_closure": ["OGMS:0000031", "BFO:0000016", "BFO:0000001", "MONDO:0006732", "BFO:0000002", "MONDO:0005071", "BFO:0000017", "BFO:0000020", "MONDO:0700096", "MONDO:0000001"], "object_label": "drug-induced dyskinesia", "object_closure_label": ["disease", "drug-induced dyskinesia", "disposition", "nervous system disorder", "continuant", "disease", "specifically dependent continuant", "realizable entity", "human disease", "entity"], "object_taxon": null, "object_taxon_label": null, "primary_knowledge_source": "infores:ctd", "aggregator_knowledge_source": ["infores:monarchinitiative"], "negated": null, "pathway": null, "evidence_count": 1, "knowledge_level": "knowledge_assertion", "agent_type": "manual_agent", "has_evidence": [], "has_evidence_links": [], "has_count": null, "has_total": null, "has_percentage": null, "has_quotient": null, "grouping_key": "CHEBI:36005||biolink:treats_or_applied_or_studied_to_treat|MONDO:0006732", "provided_by": "ctd_chemical_to_disease_edges", "provided_by_link": {"id": "ctd_chemical_to_disease", "url": "https://monarch-initiative.github.io/monarch-ingest/Sources/ctd/#chemical_to_disease"}, "publications": ["PMID:15450789"], "publications_links": [{"id": "PMID:15450789", "url": "http://identifiers.org/pubmed/15450789"}], "frequency_qualifier": null, "onset_qualifier": null, "sex_qualifier": null, "stage_qualifier": null, "qualifiers": [], "qualifiers_label": null, "qualifiers_namespace": null, "qualifiers_category": null, "qualifiers_closure": [], "qualifiers_closure_label": [], "qualifier": [], "qualifier_label": null, "qualifier_namespace": null, "qualifier_category": null, "qualifier_closure": [], "qualifier_closure_label": [], "frequency_qualifier_label": null, "frequency_qualifier_namespace": null, "frequency_qualifier_category": null, "frequency_qualifier_closure": [], "frequency_qualifier_closure_label": [], "onset_qualifier_label": null, "onset_qualifier_namespace": null, "onset_qualifier_category": null, "onset_qualifier_closure": [], "onset_qualifier_closure_label": [], "sex_qualifier_label": null, "sex_qualifier_namespace": null, "sex_qualifier_category": null, "sex_qualifier_closure": [], "sex_qualifier_closure_label": [], "stage_qualifier_label": null, "stage_qualifier_namespace": null, "stage_qualifier_category": null, "stage_qualifier_closure": [], "stage_qualifier_closure_label": []}, {"id": "uuid:4e867e8b-fd19-11ee-873f-57b99ea66a06", "category": "biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation", "subject": "CHEBI:18243", "original_subject": "MESH:D004298", "subject_namespace": "CHEBI", "subject_category": "biolink:MolecularEntity", "subject_closure": ["CHEBI:33567", "CHEBI:37577", "CHEBI:72695", "CHEBI:33285", "CHEBI:50860", "BFO:0000040", "CHEBI:33853", "CHEBI:25367", "CHEBI:33302", "CHEBI:50047", "CHEBI:25375", "CHEBI:33304", "CHEBI:64365", "CHEBI:33582", "CHEBI:33608", "BFO:0000002", "CHEBI:33570", "CHEBI:33659", "CHEBI:25806", "CHEBI:18243", "CHEBI:33655", "CHEBI:33674", "CHEBI:33566", "CHEBI:24431", "CHEBI:51143", "CHEBI:63534", "BFO:0000004", "CHEBI:36357", "BFO:0000001", "CHEBI:33675", "CHEBI:33822", "CHEBI:24651", "CHEBI:23367", "CHEBI:35352", "CHEBI:33595", "CHEBI:33832", "CHEBI:33579"], "subject_label": "dopamine", "subject_closure_label": ["hydrogen molecular entity", "chemical entity", "nitrogen molecular entity", "s-block molecular entity", "cyclic compound", "organic cyclic compound", "main group molecular entity", "organic molecular entity", "hydroxides", "organic aromatic compound", "entity", "pnictogen molecular entity", "chalcogen molecular entity", "aralkylamino compound", "carbon group molecular entity", "organic amino compound", "oxygen molecular entity", "continuant", "benzenediols", "organic molecule", "heteroorganic entity", "monoamine molecular messenger", "p-block molecular entity", "organic hydroxy compound", "material entity", "molecular entity", "catecholamine", "heteroatomic molecular entity", "aromatic compound", "dopamine", "phenols", "molecule", "organonitrogen compound", "catechols", "monoamine", "independent continuant", "polyatomic entity"], "subject_taxon": null, "subject_taxon_label": null, "predicate": "biolink:treats_or_applied_or_studied_to_treat", "object": "MONDO:0006732", "original_object": "MESH:D004409", "object_namespace": "MONDO", "object_category": "biolink:Disease", "object_closure": ["OGMS:0000031", "BFO:0000016", "BFO:0000001", "MONDO:0006732", "BFO:0000002", "MONDO:0005071", "BFO:0000017", "BFO:0000020", "MONDO:0700096", "MONDO:0000001"], "object_label": "drug-induced dyskinesia", "object_closure_label": ["disease", "drug-induced dyskinesia", "disposition", "nervous system disorder", "continuant", "disease", "specifically dependent continuant", "realizable entity", "human disease", "entity"], "object_taxon": null, "object_taxon_label": null, "primary_knowledge_source": "infores:ctd", "aggregator_knowledge_source": ["infores:monarchinitiative"], "negated": null, "pathway": null, "evidence_count": 1, "knowledge_level": "knowledge_assertion", "agent_type": "manual_agent", "has_evidence": [], "has_evidence_links": [], "has_count": null, "has_total": null, "has_percentage": null, "has_quotient": null, "grouping_key": "CHEBI:18243||biolink:treats_or_applied_or_studied_to_treat|MONDO:0006732", "provided_by": "ctd_chemical_to_disease_edges", "provided_by_link": {"id": "ctd_chemical_to_disease", "url": "https://monarch-initiative.github.io/monarch-ingest/Sources/ctd/#chemical_to_disease"}, "publications": ["PMID:189712"], "publications_links": [{"id": "PMID:189712", "url": "http://identifiers.org/pubmed/189712"}], "frequency_qualifier": null, "onset_qualifier": null, "sex_qualifier": null, "stage_qualifier": null, "qualifiers": [], "qualifiers_label": null, "qualifiers_namespace": null, "qualifiers_category": null, "qualifiers_closure": [], "qualifiers_closure_label": [], "qualifier": [], "qualifier_label": null, "qualifier_namespace": null, "qualifier_category": null, "qualifier_closure": [], "qualifier_closure_label": [], "frequency_qualifier_label": null, "frequency_qualifier_namespace": null, "frequency_qualifier_category": null, "frequency_qualifier_closure": [], "frequency_qualifier_closure_label": [], "onset_qualifier_label": null, "onset_qualifier_namespace": null, "onset_qualifier_category": null, "onset_qualifier_closure": [], "onset_qualifier_closure_label": [], "sex_qualifier_label": null, "sex_qualifier_namespace": null, "sex_qualifier_category": null, "sex_qualifier_closure": [], "sex_qualifier_closure_label": [], "stage_qualifier_label": null, "stage_qualifier_namespace": null, "stage_qualifier_category": null, "stage_qualifier_closure": [], "stage_qualifier_closure_label": []}, {"id": "uuid:4c2f776d-fd19-11ee-873f-57b99ea66a06", "category": "biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation", "subject": "CHEBI:16919", "original_subject": "MESH:D003401", "subject_namespace": "CHEBI", "subject_category": "biolink:MolecularEntity", "subject_closure": ["CHEBI:16919", "CHEBI:33285", "CHEBI:50860", "BFO:0000040", "CHEBI:33302", "CHEBI:23367", "CHEBI:33582", "CHEBI:24436", "CHEBI:83821", "BFO:0000002", "CHEBI:83811", "BFO:0000004", "CHEBI:24431", "CHEBI:51143", "BFO:0000001", "CHEBI:33675", "CHEBI:35352", "CHEBI:24373", "CHEBI:33579"], "subject_label": "creatine", "subject_closure_label": ["chemical entity", "nitrogen molecular entity", "proteinogenic amino acid derivative", "independent continuant", "glycine derivative", "main group molecular entity", "organic molecular entity", "entity", "pnictogen molecular entity", "carbon group molecular entity", "guanidines", "molecular entity", "continuant", "heteroorganic entity", "p-block molecular entity", "material entity", "amino acid derivative", "creatine", "organonitrogen compound"], "subject_taxon": null, "subject_taxon_label": null, "predicate": "biolink:treats_or_applied_or_studied_to_treat", "object": "MONDO:0006732", "original_object": "MESH:D004409", "object_namespace": "MONDO", "object_category": "biolink:Disease", "object_closure": ["OGMS:0000031", "BFO:0000016", "BFO:0000001", "MONDO:0006732", "BFO:0000002", "MONDO:0005071", "BFO:0000017", "BFO:0000020", "MONDO:0700096", "MONDO:0000001"], "object_label": "drug-induced dyskinesia", "object_closure_label": ["disease", "drug-induced dyskinesia", "disposition", "nervous system disorder", "continuant", "disease", "specifically dependent continuant", "realizable entity", "human disease", "entity"], "object_taxon": null, "object_taxon_label": null, "primary_knowledge_source": "infores:ctd", "aggregator_knowledge_source": ["infores:monarchinitiative"], "negated": null, "pathway": null, "evidence_count": 1, "knowledge_level": "knowledge_assertion", "agent_type": "manual_agent", "has_evidence": [], "has_evidence_links": [], "has_count": null, "has_total": null, "has_percentage": null, "has_quotient": null, "grouping_key": "CHEBI:16919||biolink:treats_or_applied_or_studied_to_treat|MONDO:0006732", "provided_by": "ctd_chemical_to_disease_edges", "provided_by_link": {"id": "ctd_chemical_to_disease", "url": "https://monarch-initiative.github.io/monarch-ingest/Sources/ctd/#chemical_to_disease"}, "publications": ["PMID:18762218"], "publications_links": [{"id": "PMID:18762218", "url": "http://identifiers.org/pubmed/18762218"}], "frequency_qualifier": null, "onset_qualifier": null, "sex_qualifier": null, "stage_qualifier": null, "qualifiers": [], "qualifiers_label": null, "qualifiers_namespace": null, "qualifiers_category": null, "qualifiers_closure": [], "qualifiers_closure_label": [], "qualifier": [], "qualifier_label": null, "qualifier_namespace": null, "qualifier_category": null, "qualifier_closure": [], "qualifier_closure_label": [], "frequency_qualifier_label": null, "frequency_qualifier_namespace": null, "frequency_qualifier_category": null, "frequency_qualifier_closure": [], "frequency_qualifier_closure_label": [], "onset_qualifier_label": null, "onset_qualifier_namespace": null, "onset_qualifier_category": null, "onset_qualifier_closure": [], "onset_qualifier_closure_label": [], "sex_qualifier_label": null, "sex_qualifier_namespace": null, "sex_qualifier_category": null, "sex_qualifier_closure": [], "sex_qualifier_closure_label": [], "stage_qualifier_label": null, "stage_qualifier_namespace": null, "stage_qualifier_category": null, "stage_qualifier_closure": [], "stage_qualifier_closure_label": []}, {"id": "uuid:5100527d-fd19-11ee-873f-57b99ea66a06", "category": "biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation", "subject": "CHEBI:16856", "original_subject": "MESH:D005978", "subject_namespace": "CHEBI", "subject_category": "biolink:MolecularEntity", "subject_closure": ["CHEBI:47923", "CHEBI:26835", "CHEBI:33285", "CHEBI:25676", "CHEBI:29256", "CHEBI:50860", "BFO:0000040", "CHEBI:16670", "CHEBI:33302", "CHEBI:36962", "CHEBI:37622", "CHEBI:36963", "CHEBI:23367", "CHEBI:50047", "CHEBI:33304", "CHEBI:33582", "CHEBI:83821", "CHEBI:33261", "CHEBI:33256", "CHEBI:23509", "CHEBI:83824", "CHEBI:25806", "CHEBI:83811", "BFO:0000001", "CHEBI:24431", "CHEBI:51143", "CHEBI:32988", "BFO:0000004", "CHEBI:33675", "BFO:0000002", "CHEBI:16856", "CHEBI:35352", "CHEBI:33579"], "subject_label": "glutathione", "subject_closure_label": ["chemical entity", "nitrogen molecular entity", "peptide", "glutathione", "proteinogenic amino acid derivative", "entity", "main group molecular entity", "thiol", "organic molecular entity", "continuant", "L-cysteine derivative", "primary amide", "pnictogen molecular entity", "chalcogen molecular entity", "carbon group molecular entity", "carboxamide", "organooxygen compound", "molecular entity", "organic amino compound", "organosulfur compound", "oxygen molecular entity", "heteroorganic entity", "oligopeptide", "p-block molecular entity", "material entity", "amino acid derivative", "tripeptide", "sulfur molecular entity", "organonitrogen compound", "organochalcogen compound", "cysteine derivative", "amide", "independent continuant"], "subject_taxon": null, "subject_taxon_label": null, "predicate": "biolink:treats_or_applied_or_studied_to_treat", "object": "MONDO:0006732", "original_object": "MESH:D004409", "object_namespace": "MONDO", "object_category": "biolink:Disease", "object_closure": ["OGMS:0000031", "BFO:0000016", "BFO:0000001", "MONDO:0006732", "BFO:0000002", "MONDO:0005071", "BFO:0000017", "BFO:0000020", "MONDO:0700096", "MONDO:0000001"], "object_label": "drug-induced dyskinesia", "object_closure_label": ["disease", "drug-induced dyskinesia", "disposition", "nervous system disorder", "continuant", "disease", "specifically dependent continuant", "realizable entity", "human disease", "entity"], "object_taxon": null, "object_taxon_label": null, "primary_knowledge_source": "infores:ctd", "aggregator_knowledge_source": ["infores:monarchinitiative"], "negated": null, "pathway": null, "evidence_count": 1, "knowledge_level": "knowledge_assertion", "agent_type": "manual_agent", "has_evidence": [], "has_evidence_links": [], "has_count": null, "has_total": null, "has_percentage": null, "has_quotient": null, "grouping_key": "CHEBI:16856||biolink:treats_or_applied_or_studied_to_treat|MONDO:0006732", "provided_by": "ctd_chemical_to_disease_edges", "provided_by_link": {"id": "ctd_chemical_to_disease", "url": "https://monarch-initiative.github.io/monarch-ingest/Sources/ctd/#chemical_to_disease"}, "publications": ["PMID:24406377"], "publications_links": [{"id": "PMID:24406377", "url": "http://identifiers.org/pubmed/24406377"}], "frequency_qualifier": null, "onset_qualifier": null, "sex_qualifier": null, "stage_qualifier": null, "qualifiers": [], "qualifiers_label": null, "qualifiers_namespace": null, "qualifiers_category": null, "qualifiers_closure": [], "qualifiers_closure_label": [], "qualifier": [], "qualifier_label": null, "qualifier_namespace": null, "qualifier_category": null, "qualifier_closure": [], "qualifier_closure_label": [], "frequency_qualifier_label": null, "frequency_qualifier_namespace": null, "frequency_qualifier_category": null, "frequency_qualifier_closure": [], "frequency_qualifier_closure_label": [], "onset_qualifier_label": null, "onset_qualifier_namespace": null, "onset_qualifier_category": null, "onset_qualifier_closure": [], "onset_qualifier_closure_label": [], "sex_qualifier_label": null, "sex_qualifier_namespace": null, "sex_qualifier_category": null, "sex_qualifier_closure": [], "sex_qualifier_closure_label": [], "stage_qualifier_label": null, "stage_qualifier_namespace": null, "stage_qualifier_category": null, "stage_qualifier_closure": [], "stage_qualifier_closure_label": []}, {"id": "uuid:510053c6-fd19-11ee-873f-57b99ea66a06", "category": "biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation", "subject": "CHEBI:5613", "original_subject": "MESH:D006220", "subject_namespace": "CHEBI", "subject_category": "biolink:MolecularEntity", "subject_closure": ["CHEBI:24062", "CHEBI:37577", "CHEBI:72695", "CHEBI:33285", "CHEBI:83403", "CHEBI:76224", "CHEBI:33836", "CHEBI:30879", "CHEBI:50860", "BFO:0000040", "CHEBI:33661", "CHEBI:5613", "CHEBI:22712", "CHEBI:25367", "CHEBI:33670", "CHEBI:36587", "CHEBI:23117", "CHEBI:33302", "CHEBI:36962", "CHEBI:48590", "CHEBI:36963", "CHEBI:23367", "CHEBI:37143", "CHEBI:33597", "CHEBI:33304", "CHEBI:33582", "CHEBI:23132", "CHEBI:38101", "CHEBI:37578", "CHEBI:26878", "CHEBI:33608", "CHEBI:36683", "CHEBI:17087", "CHEBI:25693", "CHEBI:33659", "CHEBI:24471", "BFO:0000001", "CHEBI:26151", "CHEBI:33598", "CHEBI:25806", "CHEBI:36586", "CHEBI:5686", "CHEBI:33655", "CHEBI:33674", "BFO:0000004", "CHEBI:24532", "CHEBI:24431", "CHEBI:51143", "CHEBI:36357", "CHEBI:33675", "CHEBI:33822", "BFO:0000002", "CHEBI:17792", "CHEBI:24651", "CHEBI:35352", "CHEBI:33595", "CHEBI:33832", "CHEBI:33579"], "subject_label": "haloperidol", "subject_closure_label": ["heteromonocyclic compound", "organic oxo compound", "chlorine molecular entity", "hydrogen molecular entity", "organochlorine compound", "chemical entity", "nitrogen molecular entity", "monocyclic compound", "haloperidol", "s-block molecular entity", "independent continuant", "cyclic compound", "organic cyclic compound", "main group molecular entity", "benzenoid aromatic compound", "alcohol", "organic molecular entity", "continuant", "organohalogen compound", "hydroxides", "ketone", "organic heteromonocyclic compound", "organic aromatic compound", "halide", "pnictogen molecular entity", "homocyclic compound", "chalcogen molecular entity", "carbon group molecular entity", "chlorobenzenes", "hydroxypiperidine", "organooxygen compound", "molecular entity", "organofluorine compound", "tertiary alcohol", "carbocyclic compound", "oxygen molecular entity", "carbonyl compound", "organic molecule", "heteroorganic entity", "p-block molecular entity", "organic hydroxy compound", "material entity", "organonitrogen heterocyclic compound", "monochlorobenzenes", "aromatic ketone", "fluorine molecular entity", "heteroatomic molecular entity", "aromatic compound", "halogen molecular entity", "entity", "piperidines", "heterocyclic compound", "benzenes", "molecule", "organonitrogen compound", "organic heterocyclic compound", "organochalcogen compound", "polyatomic entity"], "subject_taxon": null, "subject_taxon_label": null, "predicate": "biolink:treats_or_applied_or_studied_to_treat", "object": "MONDO:0006732", "original_object": "MESH:D004409", "object_namespace": "MONDO", "object_category": "biolink:Disease", "object_closure": ["OGMS:0000031", "BFO:0000016", "BFO:0000001", "MONDO:0006732", "BFO:0000002", "MONDO:0005071", "BFO:0000017", "BFO:0000020", "MONDO:0700096", "MONDO:0000001"], "object_label": "drug-induced dyskinesia", "object_closure_label": ["disease", "drug-induced dyskinesia", "disposition", "nervous system disorder", "continuant", "disease", "specifically dependent continuant", "realizable entity", "human disease", "entity"], "object_taxon": null, "object_taxon_label": null, "primary_knowledge_source": "infores:ctd", "aggregator_knowledge_source": ["infores:monarchinitiative"], "negated": null, "pathway": null, "evidence_count": 4, "knowledge_level": "knowledge_assertion", "agent_type": "manual_agent", "has_evidence": [], "has_evidence_links": [], "has_count": null, "has_total": null, "has_percentage": null, "has_quotient": null, "grouping_key": "CHEBI:5613||biolink:treats_or_applied_or_studied_to_treat|MONDO:0006732", "provided_by": "ctd_chemical_to_disease_edges", "provided_by_link": {"id": "ctd_chemical_to_disease", "url": "https://monarch-initiative.github.io/monarch-ingest/Sources/ctd/#chemical_to_disease"}, "publications": ["PMID:16960862", "PMID:18707801", "PMID:4718286", "PMID:945166"], "publications_links": [{"id": "PMID:16960862", "url": "http://identifiers.org/pubmed/16960862"}, {"id": "PMID:18707801", "url": "http://identifiers.org/pubmed/18707801"}, {"id": "PMID:4718286", "url": "http://identifiers.org/pubmed/4718286"}, {"id": "PMID:945166", "url": "http://identifiers.org/pubmed/945166"}], "frequency_qualifier": null, "onset_qualifier": null, "sex_qualifier": null, "stage_qualifier": null, "qualifiers": [], "qualifiers_label": null, "qualifiers_namespace": null, "qualifiers_category": null, "qualifiers_closure": [], "qualifiers_closure_label": [], "qualifier": [], "qualifier_label": null, "qualifier_namespace": null, "qualifier_category": null, "qualifier_closure": [], "qualifier_closure_label": [], "frequency_qualifier_label": null, "frequency_qualifier_namespace": null, "frequency_qualifier_category": null, "frequency_qualifier_closure": [], "frequency_qualifier_closure_label": [], "onset_qualifier_label": null, "onset_qualifier_namespace": null, "onset_qualifier_category": null, "onset_qualifier_closure": [], "onset_qualifier_closure_label": [], "sex_qualifier_label": null, "sex_qualifier_namespace": null, "sex_qualifier_category": null, "sex_qualifier_closure": [], "sex_qualifier_closure_label": [], "stage_qualifier_label": null, "stage_qualifier_namespace": null, "stage_qualifier_category": null, "stage_qualifier_closure": [], "stage_qualifier_closure_label": []}, {"id": "uuid:5307712f-fd19-11ee-873f-57b99ea66a06", "category": "biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation", "subject": "CHEBI:15765", "original_subject": "MESH:D007980", "subject_namespace": "CHEBI", "subject_category": "biolink:MolecularEntity", "subject_closure": ["CHEBI:37577", "CHEBI:72695", "CHEBI:33285", "CHEBI:84144", "CHEBI:33856", "CHEBI:25985", "CHEBI:50860", "BFO:0000040", "CHEBI:62761", "CHEBI:25367", "CHEBI:36587", "CHEBI:33302", "CHEBI:27177", "CHEBI:36962", "CHEBI:36963", "CHEBI:23367", "CHEBI:50047", "CHEBI:83822", "CHEBI:33304", "CHEBI:33582", "CHEBI:83821", "CHEBI:15705", "CHEBI:33709", "CHEBI:33704", "CHEBI:33608", "BFO:0000002", "CHEBI:24833", "CHEBI:33659", "CHEBI:64709", "CHEBI:24734", "CHEBI:33575", "CHEBI:25806", "CHEBI:36586", "CHEBI:33655", "CHEBI:83925", "CHEBI:83811", "CHEBI:33674", "BFO:0000004", "CHEBI:49168", "CHEBI:83820", "CHEBI:24431", "CHEBI:51143", "CHEBI:15765", "CHEBI:36357", "BFO:0000001", "CHEBI:33675", "CHEBI:35605", "CHEBI:24651", "CHEBI:24662", "CHEBI:35352", "CHEBI:33595", "CHEBI:33832", "CHEBI:33579"], "subject_label": "L-dopa", "subject_closure_label": ["organic oxo compound", "alpha-amino acid", "hydrogen molecular entity", "chemical entity", "nitrogen molecular entity", "proteinogenic amino acid derivative", "s-block molecular entity", "independent continuant", "cyclic compound", "organic cyclic compound", "main group molecular entity", "phenylalanine derivative", "organic molecular entity", "carbon oxoacid", "hydroxides", "hydroxy-amino acid", "oxoacid", "organic aromatic compound", "non-proteinogenic L-alpha-amino acid", "entity", "pnictogen molecular entity", "L-tyrosine derivative", "chalcogen molecular entity", "carbon group molecular entity", "organooxygen compound", "molecular entity", "organic amino compound", "oxygen molecular entity", "carbonyl compound", "continuant", "organic molecule", "heteroorganic entity", "L-phenylalanine derivative", "aromatic amino acid", "L-alpha-amino acid", "amino acid", "p-block molecular entity", "material entity", "amino acid derivative", "heteroatomic molecular entity", "aromatic compound", "non-proteinogenic alpha-amino acid", "organic acid", "hydroxyphenylalanine", "carboxylic acid", "non-proteinogenic amino acid", "tyrosine derivative", "molecule", "organonitrogen compound", "organochalcogen compound", "dopa", "L-dopa", "polyatomic entity"], "subject_taxon": null, "subject_taxon_label": null, "predicate": "biolink:treats_or_applied_or_studied_to_treat", "object": "MONDO:0006732", "original_object": "MESH:D004409", "object_namespace": "MONDO", "object_category": "biolink:Disease", "object_closure": ["OGMS:0000031", "BFO:0000016", "BFO:0000001", "MONDO:0006732", "BFO:0000002", "MONDO:0005071", "BFO:0000017", "BFO:0000020", "MONDO:0700096", "MONDO:0000001"], "object_label": "drug-induced dyskinesia", "object_closure_label": ["disease", "drug-induced dyskinesia", "disposition", "nervous system disorder", "continuant", "disease", "specifically dependent continuant", "realizable entity", "human disease", "entity"], "object_taxon": null, "object_taxon_label": null, "primary_knowledge_source": "infores:ctd", "aggregator_knowledge_source": ["infores:monarchinitiative"], "negated": null, "pathway": null, "evidence_count": 1, "knowledge_level": "knowledge_assertion", "agent_type": "manual_agent", "has_evidence": [], "has_evidence_links": [], "has_count": null, "has_total": null, "has_percentage": null, "has_quotient": null, "grouping_key": "CHEBI:15765||biolink:treats_or_applied_or_studied_to_treat|MONDO:0006732", "provided_by": "ctd_chemical_to_disease_edges", "provided_by_link": {"id": "ctd_chemical_to_disease", "url": "https://monarch-initiative.github.io/monarch-ingest/Sources/ctd/#chemical_to_disease"}, "publications": ["PMID:19048950"], "publications_links": [{"id": "PMID:19048950", "url": "http://identifiers.org/pubmed/19048950"}], "frequency_qualifier": null, "onset_qualifier": null, "sex_qualifier": null, "stage_qualifier": null, "qualifiers": [], "qualifiers_label": null, "qualifiers_namespace": null, "qualifiers_category": null, "qualifiers_closure": [], "qualifiers_closure_label": [], "qualifier": [], "qualifier_label": null, "qualifier_namespace": null, "qualifier_category": null, "qualifier_closure": [], "qualifier_closure_label": [], "frequency_qualifier_label": null, "frequency_qualifier_namespace": null, "frequency_qualifier_category": null, "frequency_qualifier_closure": [], "frequency_qualifier_closure_label": [], "onset_qualifier_label": null, "onset_qualifier_namespace": null, "onset_qualifier_category": null, "onset_qualifier_closure": [], "onset_qualifier_closure_label": [], "sex_qualifier_label": null, "sex_qualifier_namespace": null, "sex_qualifier_category": null, "sex_qualifier_closure": [], "sex_qualifier_closure_label": [], "stage_qualifier_label": null, "stage_qualifier_namespace": null, "stage_qualifier_category": null, "stage_qualifier_closure": [], "stage_qualifier_closure_label": []}, {"id": "uuid:54cf1f6b-fd19-11ee-873f-57b99ea66a06", "category": "biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation", "subject": "CHEBI:17303", "original_subject": "MESH:D009020", "subject_namespace": "CHEBI", "subject_category": "biolink:MolecularEntity", "subject_closure": ["CHEBI:22315", "CHEBI:72695", "CHEBI:33285", "CHEBI:33671", "CHEBI:50860", "BFO:0000040", "CHEBI:25367", "CHEBI:33302", "CHEBI:50047", "CHEBI:38164", "CHEBI:33582", "CHEBI:38166", "CHEBI:5686", "CHEBI:25418", "BFO:0000004", "CHEBI:50996", "CHEBI:33635", "CHEBI:24532", "CHEBI:17303", "CHEBI:24431", "CHEBI:51143", "CHEBI:36357", "BFO:0000001", "CHEBI:33675", "BFO:0000002", "CHEBI:23367", "CHEBI:35352", "CHEBI:24921", "CHEBI:33595", "CHEBI:33832", "CHEBI:33579"], "subject_label": "morphine", "subject_closure_label": ["chemical entity", "nitrogen molecular entity", "morphinane alkaloid", "independent continuant", "cyclic compound", "organic cyclic compound", "main group molecular entity", "heteropolycyclic compound", "organic molecular entity", "continuant", "entity", "pnictogen molecular entity", "carbon group molecular entity", "organic amino compound", "organic molecule", "heteroorganic entity", "p-block molecular entity", "material entity", "organic heteropolycyclic compound", "molecular entity", "alkaloid", "organic heteropentacyclic compound", "morphine", "heterocyclic compound", "molecule", "organonitrogen compound", "isoquinoline alkaloid", "tertiary amino compound", "polycyclic compound", "organic heterocyclic compound", "polyatomic entity"], "subject_taxon": null, "subject_taxon_label": null, "predicate": "biolink:treats_or_applied_or_studied_to_treat", "object": "MONDO:0006732", "original_object": "MESH:D004409", "object_namespace": "MONDO", "object_category": "biolink:Disease", "object_closure": ["OGMS:0000031", "BFO:0000016", "BFO:0000001", "MONDO:0006732", "BFO:0000002", "MONDO:0005071", "BFO:0000017", "BFO:0000020", "MONDO:0700096", "MONDO:0000001"], "object_label": "drug-induced dyskinesia", "object_closure_label": ["disease", "drug-induced dyskinesia", "disposition", "nervous system disorder", "continuant", "disease", "specifically dependent continuant", "realizable entity", "human disease", "entity"], "object_taxon": null, "object_taxon_label": null, "primary_knowledge_source": "infores:ctd", "aggregator_knowledge_source": ["infores:monarchinitiative"], "negated": null, "pathway": null, "evidence_count": 2, "knowledge_level": "knowledge_assertion", "agent_type": "manual_agent", "has_evidence": [], "has_evidence_links": [], "has_count": null, "has_total": null, "has_percentage": null, "has_quotient": null, "grouping_key": "CHEBI:17303||biolink:treats_or_applied_or_studied_to_treat|MONDO:0006732", "provided_by": "ctd_chemical_to_disease_edges", "provided_by_link": {"id": "ctd_chemical_to_disease", "url": "https://monarch-initiative.github.io/monarch-ingest/Sources/ctd/#chemical_to_disease"}, "publications": ["PMID:10907730", "PMID:15207281"], "publications_links": [{"id": "PMID:10907730", "url": "http://identifiers.org/pubmed/10907730"}, {"id": "PMID:15207281", "url": "http://identifiers.org/pubmed/15207281"}], "frequency_qualifier": null, "onset_qualifier": null, "sex_qualifier": null, "stage_qualifier": null, "qualifiers": [], "qualifiers_label": null, "qualifiers_namespace": null, "qualifiers_category": null, "qualifiers_closure": [], "qualifiers_closure_label": [], "qualifier": [], "qualifier_label": null, "qualifier_namespace": null, "qualifier_category": null, "qualifier_closure": [], "qualifier_closure_label": [], "frequency_qualifier_label": null, "frequency_qualifier_namespace": null, "frequency_qualifier_category": null, "frequency_qualifier_closure": [], "frequency_qualifier_closure_label": [], "onset_qualifier_label": null, "onset_qualifier_namespace": null, "onset_qualifier_category": null, "onset_qualifier_closure": [], "onset_qualifier_closure_label": [], "sex_qualifier_label": null, "sex_qualifier_namespace": null, "sex_qualifier_category": null, "sex_qualifier_closure": [], "sex_qualifier_closure_label": [], "stage_qualifier_label": null, "stage_qualifier_namespace": null, "stage_qualifier_category": null, "stage_qualifier_closure": [], "stage_qualifier_closure_label": []}, {"id": "uuid:55d3d86f-fd19-11ee-873f-57b99ea66a06", "category": "biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation", "subject": "CHEBI:17688", "original_subject": "MESH:D009538", "subject_namespace": "CHEBI", "subject_category": "biolink:MolecularEntity", "subject_closure": ["CHEBI:22315", "CHEBI:138000", "CHEBI:72695", "CHEBI:33285", "CHEBI:50860", "CHEBI:38260", "BFO:0000040", "CHEBI:33661", "CHEBI:25367", "CHEBI:33670", "CHEBI:33302", "CHEBI:23367", "CHEBI:50047", "BFO:0000001", "CHEBI:33582", "CHEBI:38101", "CHEBI:25693", "CHEBI:5686", "BFO:0000004", "CHEBI:50996", "CHEBI:24532", "CHEBI:26421", "CHEBI:24431", "CHEBI:51143", "CHEBI:36357", "CHEBI:46775", "CHEBI:17688", "CHEBI:33675", "BFO:0000002", "CHEBI:35352", "CHEBI:26456", "CHEBI:26416", "CHEBI:33595", "CHEBI:33832", "CHEBI:33579"], "subject_label": "(S)-nicotine", "subject_closure_label": ["heteromonocyclic compound", "chemical entity", "nitrogen molecular entity", "monocyclic compound", "independent continuant", "cyclic compound", "organic cyclic compound", "main group molecular entity", "organic molecular entity", "pyrrolidines", "continuant", "N-alkylpyrrolidine", "organic heteromonocyclic compound", "pnictogen molecular entity", "carbon group molecular entity", "molecular entity", "organic amino compound", "organic molecule", "heteroorganic entity", "(S)-nicotine", "p-block molecular entity", "material entity", "organonitrogen heterocyclic compound", "alkaloid", "3-(1-methylpyrrolidin-2-yl)pyridine", "pyridines", "heterocyclic compound", "molecule", "organonitrogen compound", "pyrrolidine alkaloid", "pyridine alkaloid", "tertiary amino compound", "organic heterocyclic compound", "polyatomic entity", "entity"], "subject_taxon": null, "subject_taxon_label": null, "predicate": "biolink:treats_or_applied_or_studied_to_treat", "object": "MONDO:0006732", "original_object": "MESH:D004409", "object_namespace": "MONDO", "object_category": "biolink:Disease", "object_closure": ["OGMS:0000031", "BFO:0000016", "BFO:0000001", "MONDO:0006732", "BFO:0000002", "MONDO:0005071", "BFO:0000017", "BFO:0000020", "MONDO:0700096", "MONDO:0000001"], "object_label": "drug-induced dyskinesia", "object_closure_label": ["disease", "drug-induced dyskinesia", "disposition", "nervous system disorder", "continuant", "disease", "specifically dependent continuant", "realizable entity", "human disease", "entity"], "object_taxon": null, "object_taxon_label": null, "primary_knowledge_source": "infores:ctd", "aggregator_knowledge_source": ["infores:monarchinitiative"], "negated": null, "pathway": null, "evidence_count": 4, "knowledge_level": "knowledge_assertion", "agent_type": "manual_agent", "has_evidence": [], "has_evidence_links": [], "has_count": null, "has_total": null, "has_percentage": null, "has_quotient": null, "grouping_key": "CHEBI:17688||biolink:treats_or_applied_or_studied_to_treat|MONDO:0006732", "provided_by": "ctd_chemical_to_disease_edges", "provided_by_link": {"id": "ctd_chemical_to_disease", "url": "https://monarch-initiative.github.io/monarch-ingest/Sources/ctd/#chemical_to_disease"}, "publications": ["PMID:17960553", "PMID:18650244", "PMID:20200117", "PMID:21232546"], "publications_links": [{"id": "PMID:17960553", "url": "http://identifiers.org/pubmed/17960553"}, {"id": "PMID:18650244", "url": "http://identifiers.org/pubmed/18650244"}, {"id": "PMID:20200117", "url": "http://identifiers.org/pubmed/20200117"}, {"id": "PMID:21232546", "url": "http://identifiers.org/pubmed/21232546"}], "frequency_qualifier": null, "onset_qualifier": null, "sex_qualifier": null, "stage_qualifier": null, "qualifiers": [], "qualifiers_label": null, "qualifiers_namespace": null, "qualifiers_category": null, "qualifiers_closure": [], "qualifiers_closure_label": [], "qualifier": [], "qualifier_label": null, "qualifier_namespace": null, "qualifier_category": null, "qualifier_closure": [], "qualifier_closure_label": [], "frequency_qualifier_label": null, "frequency_qualifier_namespace": null, "frequency_qualifier_category": null, "frequency_qualifier_closure": [], "frequency_qualifier_closure_label": [], "onset_qualifier_label": null, "onset_qualifier_namespace": null, "onset_qualifier_category": null, "onset_qualifier_closure": [], "onset_qualifier_closure_label": [], "sex_qualifier_label": null, "sex_qualifier_namespace": null, "sex_qualifier_category": null, "sex_qualifier_closure": [], "sex_qualifier_closure_label": [], "stage_qualifier_label": null, "stage_qualifier_namespace": null, "stage_qualifier_category": null, "stage_qualifier_closure": [], "stage_qualifier_closure_label": []}, {"id": "uuid:5677e3f2-fd19-11ee-873f-57b99ea66a06", "category": "biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation", "subject": "CHEBI:7735", "original_subject": "MESH:D000077152", "subject_namespace": "CHEBI", "subject_category": "biolink:MolecularEntity", "subject_closure": ["CHEBI:72695", "CHEBI:33285", "CHEBI:33671", "CHEBI:50860", "BFO:0000040", "CHEBI:33661", "CHEBI:25367", "CHEBI:33670", "CHEBI:33302", "CHEBI:23367", "CHEBI:50047", "CHEBI:33860", "CHEBI:46920", "CHEBI:33582", "CHEBI:38166", "CHEBI:38101", "CHEBI:7735", "CHEBI:22720", "CHEBI:25693", "CHEBI:33659", "CHEBI:46848", "CHEBI:5686", "CHEBI:33655", "CHEBI:50996", "CHEBI:33635", "CHEBI:24532", "CHEBI:24431", "CHEBI:51143", "BFO:0000004", "CHEBI:36357", "CHEBI:26144", "BFO:0000001", "CHEBI:33675", "CHEBI:46845", "BFO:0000002", "CHEBI:35352", "CHEBI:33595", "CHEBI:33832", "CHEBI:33579"], "subject_label": "olanzapine", "subject_closure_label": ["heteromonocyclic compound", "benzodiazepine", "chemical entity", "nitrogen molecular entity", "monocyclic compound", "cyclic compound", "organic cyclic compound", "main group molecular entity", "heteropolycyclic compound", "organic molecular entity", "continuant", "organic heteromonocyclic compound", "organic aromatic compound", "aromatic amine", "entity", "pnictogen molecular entity", "carbon group molecular entity", "molecular entity", "organic amino compound", "olanzapine", "N-arylpiperazine", "organic molecule", "heteroorganic entity", "p-block molecular entity", "N-alkylpiperazine", "material entity", "organic heteropolycyclic compound", "organonitrogen heterocyclic compound", "aromatic compound", "N-methylpiperazine", "heterocyclic compound", "molecule", "organonitrogen compound", "tertiary amino compound", "polycyclic compound", "organic heterocyclic compound", "independent continuant", "polyatomic entity", "piperazines"], "subject_taxon": null, "subject_taxon_label": null, "predicate": "biolink:treats_or_applied_or_studied_to_treat", "object": "MONDO:0006732", "original_object": "MESH:D004409", "object_namespace": "MONDO", "object_category": "biolink:Disease", "object_closure": ["OGMS:0000031", "BFO:0000016", "BFO:0000001", "MONDO:0006732", "BFO:0000002", "MONDO:0005071", "BFO:0000017", "BFO:0000020", "MONDO:0700096", "MONDO:0000001"], "object_label": "drug-induced dyskinesia", "object_closure_label": ["disease", "drug-induced dyskinesia", "disposition", "nervous system disorder", "continuant", "disease", "specifically dependent continuant", "realizable entity", "human disease", "entity"], "object_taxon": null, "object_taxon_label": null, "primary_knowledge_source": "infores:ctd", "aggregator_knowledge_source": ["infores:monarchinitiative"], "negated": null, "pathway": null, "evidence_count": 2, "knowledge_level": "knowledge_assertion", "agent_type": "manual_agent", "has_evidence": [], "has_evidence_links": [], "has_count": null, "has_total": null, "has_percentage": null, "has_quotient": null, "grouping_key": "CHEBI:7735||biolink:treats_or_applied_or_studied_to_treat|MONDO:0006732", "provided_by": "ctd_chemical_to_disease_edges", "provided_by_link": {"id": "ctd_chemical_to_disease", "url": "https://monarch-initiative.github.io/monarch-ingest/Sources/ctd/#chemical_to_disease"}, "publications": ["PMID:12224042", "PMID:12661802"], "publications_links": [{"id": "PMID:12224042", "url": "http://identifiers.org/pubmed/12224042"}, {"id": "PMID:12661802", "url": "http://identifiers.org/pubmed/12661802"}], "frequency_qualifier": null, "onset_qualifier": null, "sex_qualifier": null, "stage_qualifier": null, "qualifiers": [], "qualifiers_label": null, "qualifiers_namespace": null, "qualifiers_category": null, "qualifiers_closure": [], "qualifiers_closure_label": [], "qualifier": [], "qualifier_label": null, "qualifier_namespace": null, "qualifier_category": null, "qualifier_closure": [], "qualifier_closure_label": [], "frequency_qualifier_label": null, "frequency_qualifier_namespace": null, "frequency_qualifier_category": null, "frequency_qualifier_closure": [], "frequency_qualifier_closure_label": [], "onset_qualifier_label": null, "onset_qualifier_namespace": null, "onset_qualifier_category": null, "onset_qualifier_closure": [], "onset_qualifier_closure_label": [], "sex_qualifier_label": null, "sex_qualifier_namespace": null, "sex_qualifier_category": null, "sex_qualifier_closure": [], "sex_qualifier_closure_label": [], "stage_qualifier_label": null, "stage_qualifier_namespace": null, "stage_qualifier_category": null, "stage_qualifier_closure": [], "stage_qualifier_closure_label": []}, {"id": "uuid:5887b486-fd19-11ee-873f-57b99ea66a06", "category": "biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation", "subject": "CHEBI:17026", "original_subject": "MESH:D011374", "subject_namespace": "CHEBI", "subject_category": "biolink:MolecularEntity", "subject_closure": ["CHEBI:3992", "CHEBI:64600", "CHEBI:72695", "CHEBI:33285", "CHEBI:51958", "CHEBI:51689", "CHEBI:78840", "CHEBI:47788", "CHEBI:50860", "CHEBI:25367", "CHEBI:51721", "CHEBI:61313", "CHEBI:36587", "CHEBI:36962", "CHEBI:36963", "CHEBI:23367", "BFO:0000001", "CHEBI:18059", "CHEBI:33304", "CHEBI:33582", "BFO:0000040", "CHEBI:17087", "CHEBI:17026", "CHEBI:36885", "CHEBI:25806", "CHEBI:36586", "BFO:0000002", "BFO:0000004", "CHEBI:33635", "CHEBI:26764", "CHEBI:24431", "CHEBI:35789", "CHEBI:36357", "CHEBI:33675", "CHEBI:35341", "CHEBI:47909", "CHEBI:33595", "CHEBI:33832", "CHEBI:33579"], "subject_label": "progesterone", "subject_closure_label": ["organic oxo compound", "continuant", "chemical entity", "organic polycyclic compound", "independent continuant", "cyclic compound", "organic cyclic compound", "main group molecular entity", "olefinic compound", "3-oxo steroid", "organic molecular entity", "ketone", "progesterone", "lipid", "chalcogen molecular entity", "carbon group molecular entity", "organooxygen compound", "molecular entity", "oxygen molecular entity", "carbonyl compound", "material entity", "organic molecule", "heteroorganic entity", "alpha,beta-unsaturated ketone", "C21-steroid", "p-block molecular entity", "steroid", "enone", "cyclic ketone", "C21-steroid hormone", "oxo steroid", "20-oxo steroid", "steroid hormone", "molecule", "3-oxo-Delta(4) steroid", "polycyclic compound", "organochalcogen compound", "polyatomic entity", "entity"], "subject_taxon": null, "subject_taxon_label": null, "predicate": "biolink:treats_or_applied_or_studied_to_treat", "object": "MONDO:0006732", "original_object": "MESH:D004409", "object_namespace": "MONDO", "object_category": "biolink:Disease", "object_closure": ["OGMS:0000031", "BFO:0000016", "BFO:0000001", "MONDO:0006732", "BFO:0000002", "MONDO:0005071", "BFO:0000017", "BFO:0000020", "MONDO:0700096", "MONDO:0000001"], "object_label": "drug-induced dyskinesia", "object_closure_label": ["disease", "drug-induced dyskinesia", "disposition", "nervous system disorder", "continuant", "disease", "specifically dependent continuant", "realizable entity", "human disease", "entity"], "object_taxon": null, "object_taxon_label": null, "primary_knowledge_source": "infores:ctd", "aggregator_knowledge_source": ["infores:monarchinitiative"], "negated": null, "pathway": null, "evidence_count": 1, "knowledge_level": "knowledge_assertion", "agent_type": "manual_agent", "has_evidence": [], "has_evidence_links": [], "has_count": null, "has_total": null, "has_percentage": null, "has_quotient": null, "grouping_key": "CHEBI:17026||biolink:treats_or_applied_or_studied_to_treat|MONDO:0006732", "provided_by": "ctd_chemical_to_disease_edges", "provided_by_link": {"id": "ctd_chemical_to_disease", "url": "https://monarch-initiative.github.io/monarch-ingest/Sources/ctd/#chemical_to_disease"}, "publications": ["PMID:17988775"], "publications_links": [{"id": "PMID:17988775", "url": "http://identifiers.org/pubmed/17988775"}], "frequency_qualifier": null, "onset_qualifier": null, "sex_qualifier": null, "stage_qualifier": null, "qualifiers": [], "qualifiers_label": null, "qualifiers_namespace": null, "qualifiers_category": null, "qualifiers_closure": [], "qualifiers_closure_label": [], "qualifier": [], "qualifier_label": null, "qualifier_namespace": null, "qualifier_category": null, "qualifier_closure": [], "qualifier_closure_label": [], "frequency_qualifier_label": null, "frequency_qualifier_namespace": null, "frequency_qualifier_category": null, "frequency_qualifier_closure": [], "frequency_qualifier_closure_label": [], "onset_qualifier_label": null, "onset_qualifier_namespace": null, "onset_qualifier_category": null, "onset_qualifier_closure": [], "onset_qualifier_closure_label": [], "sex_qualifier_label": null, "sex_qualifier_namespace": null, "sex_qualifier_category": null, "sex_qualifier_closure": [], "sex_qualifier_closure_label": [], "stage_qualifier_label": null, "stage_qualifier_namespace": null, "stage_qualifier_category": null, "stage_qualifier_closure": [], "stage_qualifier_closure_label": []}, {"id": "uuid:53a9e381-fd19-11ee-873f-57b99ea66a06", "category": "biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation", "subject": "CHEBI:16796", "original_subject": "MESH:D008550", "subject_namespace": "CHEBI", "subject_category": "biolink:MolecularEntity", "subject_closure": ["CHEBI:27162", "CHEBI:16796", "CHEBI:72695", "CHEBI:33285", "CHEBI:24828", "CHEBI:33671", "CHEBI:50860", "BFO:0000040", "CHEBI:33672", "CHEBI:25367", "CHEBI:33302", "CHEBI:36962", "CHEBI:37622", "CHEBI:36963", "CHEBI:23367", "BFO:0000001", "CHEBI:33833", "CHEBI:33304", "CHEBI:33582", "CHEBI:38166", "CHEBI:22160", "CHEBI:38101", "CHEBI:27171", "CHEBI:33256", "CHEBI:33659", "CHEBI:22728", "CHEBI:33636", "CHEBI:25806", "CHEBI:5686", "CHEBI:33655", "CHEBI:38180", "CHEBI:33635", "CHEBI:24532", "CHEBI:24431", "CHEBI:51143", "CHEBI:32988", "BFO:0000004", "CHEBI:36357", "CHEBI:33675", "BFO:0000002", "CHEBI:35352", "CHEBI:33595", "CHEBI:33832", "CHEBI:33579"], "subject_label": "melatonin", "subject_closure_label": ["chemical entity", "nitrogen molecular entity", "heterobicyclic compound", "cyclic compound", "organic cyclic compound", "main group molecular entity", "heteropolycyclic compound", "organic molecular entity", "continuant", "organic aromatic compound", "primary amide", "pnictogen molecular entity", "heteroarene", "chalcogen molecular entity", "carbon group molecular entity", "carboxamide", "organooxygen compound", "molecular entity", "oxygen molecular entity", "melatonin", "organic molecule", "heteroorganic entity", "organic heterobicyclic compound", "p-block molecular entity", "material entity", "organic heteropolycyclic compound", "acetamides", "organonitrogen heterocyclic compound", "indoles", "tryptamines", "aromatic compound", "polycyclic heteroarene", "benzopyrrole", "bicyclic compound", "heterocyclic compound", "molecule", "organonitrogen compound", "polycyclic compound", "organic heterocyclic compound", "organochalcogen compound", "amide", "independent continuant", "polyatomic entity", "entity"], "subject_taxon": null, "subject_taxon_label": null, "predicate": "biolink:treats_or_applied_or_studied_to_treat", "object": "MONDO:0006732", "original_object": "MESH:D004409", "object_namespace": "MONDO", "object_category": "biolink:Disease", "object_closure": ["OGMS:0000031", "BFO:0000016", "BFO:0000001", "MONDO:0006732", "BFO:0000002", "MONDO:0005071", "BFO:0000017", "BFO:0000020", "MONDO:0700096", "MONDO:0000001"], "object_label": "drug-induced dyskinesia", "object_closure_label": ["disease", "drug-induced dyskinesia", "disposition", "nervous system disorder", "continuant", "disease", "specifically dependent continuant", "realizable entity", "human disease", "entity"], "object_taxon": null, "object_taxon_label": null, "primary_knowledge_source": "infores:ctd", "aggregator_knowledge_source": ["infores:monarchinitiative"], "negated": null, "pathway": null, "evidence_count": 1, "knowledge_level": "knowledge_assertion", "agent_type": "manual_agent", "has_evidence": [], "has_evidence_links": [], "has_count": null, "has_total": null, "has_percentage": null, "has_quotient": null, "grouping_key": "CHEBI:16796||biolink:treats_or_applied_or_studied_to_treat|MONDO:0006732", "provided_by": "ctd_chemical_to_disease_edges", "provided_by_link": {"id": "ctd_chemical_to_disease", "url": "https://monarch-initiative.github.io/monarch-ingest/Sources/ctd/#chemical_to_disease"}, "publications": ["PMID:12543230"], "publications_links": [{"id": "PMID:12543230", "url": "http://identifiers.org/pubmed/12543230"}], "frequency_qualifier": null, "onset_qualifier": null, "sex_qualifier": null, "stage_qualifier": null, "qualifiers": [], "qualifiers_label": null, "qualifiers_namespace": null, "qualifiers_category": null, "qualifiers_closure": [], "qualifiers_closure_label": [], "qualifier": [], "qualifier_label": null, "qualifier_namespace": null, "qualifier_category": null, "qualifier_closure": [], "qualifier_closure_label": [], "frequency_qualifier_label": null, "frequency_qualifier_namespace": null, "frequency_qualifier_category": null, "frequency_qualifier_closure": [], "frequency_qualifier_closure_label": [], "onset_qualifier_label": null, "onset_qualifier_namespace": null, "onset_qualifier_category": null, "onset_qualifier_closure": [], "onset_qualifier_closure_label": [], "sex_qualifier_label": null, "sex_qualifier_namespace": null, "sex_qualifier_category": null, "sex_qualifier_closure": [], "sex_qualifier_closure_label": [], "stage_qualifier_label": null, "stage_qualifier_namespace": null, "stage_qualifier_category": null, "stage_qualifier_closure": [], "stage_qualifier_closure_label": []}, {"id": "uuid:5b2474e6-fd19-11ee-873f-57b99ea66a06", "category": "biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation", "subject": "CHEBI:41774", "original_subject": "MESH:D013629", "subject_namespace": "CHEBI", "subject_category": "biolink:MolecularEntity", "subject_closure": ["CHEBI:72695", "CHEBI:33285", "CHEBI:78840", "CHEBI:50860", "BFO:0000040", "CHEBI:25367", "CHEBI:41774", "CHEBI:33302", "CHEBI:50047", "CHEBI:33582", "CHEBI:26776", "CHEBI:33659", "BFO:0000001", "CHEBI:33655", "BFO:0000004", "CHEBI:50996", "CHEBI:24431", "CHEBI:51143", "CHEBI:36357", "CHEBI:33675", "BFO:0000002", "CHEBI:23367", "CHEBI:35352", "CHEBI:33595", "CHEBI:33832", "CHEBI:33579"], "subject_label": "tamoxifen", "subject_closure_label": ["tamoxifen", "chemical entity", "nitrogen molecular entity", "independent continuant", "cyclic compound", "organic cyclic compound", "main group molecular entity", "olefinic compound", "organic molecular entity", "continuant", "stilbenoid", "organic aromatic compound", "pnictogen molecular entity", "carbon group molecular entity", "organic amino compound", "organic molecule", "heteroorganic entity", "p-block molecular entity", "material entity", "molecular entity", "aromatic compound", "entity", "molecule", "organonitrogen compound", "tertiary amino compound", "polyatomic entity"], "subject_taxon": null, "subject_taxon_label": null, "predicate": "biolink:treats_or_applied_or_studied_to_treat", "object": "MONDO:0006732", "original_object": "MESH:D004409", "object_namespace": "MONDO", "object_category": "biolink:Disease", "object_closure": ["OGMS:0000031", "BFO:0000016", "BFO:0000001", "MONDO:0006732", "BFO:0000002", "MONDO:0005071", "BFO:0000017", "BFO:0000020", "MONDO:0700096", "MONDO:0000001"], "object_label": "drug-induced dyskinesia", "object_closure_label": ["disease", "drug-induced dyskinesia", "disposition", "nervous system disorder", "continuant", "disease", "specifically dependent continuant", "realizable entity", "human disease", "entity"], "object_taxon": null, "object_taxon_label": null, "primary_knowledge_source": "infores:ctd", "aggregator_knowledge_source": ["infores:monarchinitiative"], "negated": null, "pathway": null, "evidence_count": 1, "knowledge_level": "knowledge_assertion", "agent_type": "manual_agent", "has_evidence": [], "has_evidence_links": [], "has_count": null, "has_total": null, "has_percentage": null, "has_quotient": null, "grouping_key": "CHEBI:41774||biolink:treats_or_applied_or_studied_to_treat|MONDO:0006732", "provided_by": "ctd_chemical_to_disease_edges", "provided_by_link": {"id": "ctd_chemical_to_disease", "url": "https://monarch-initiative.github.io/monarch-ingest/Sources/ctd/#chemical_to_disease"}, "publications": ["PMID:17116309"], "publications_links": [{"id": "PMID:17116309", "url": "http://identifiers.org/pubmed/17116309"}], "frequency_qualifier": null, "onset_qualifier": null, "sex_qualifier": null, "stage_qualifier": null, "qualifiers": [], "qualifiers_label": null, "qualifiers_namespace": null, "qualifiers_category": null, "qualifiers_closure": [], "qualifiers_closure_label": [], "qualifier": [], "qualifier_label": null, "qualifier_namespace": null, "qualifier_category": null, "qualifier_closure": [], "qualifier_closure_label": [], "frequency_qualifier_label": null, "frequency_qualifier_namespace": null, "frequency_qualifier_category": null, "frequency_qualifier_closure": [], "frequency_qualifier_closure_label": [], "onset_qualifier_label": null, "onset_qualifier_namespace": null, "onset_qualifier_category": null, "onset_qualifier_closure": [], "onset_qualifier_closure_label": [], "sex_qualifier_label": null, "sex_qualifier_namespace": null, "sex_qualifier_category": null, "sex_qualifier_closure": [], "sex_qualifier_closure_label": [], "stage_qualifier_label": null, "stage_qualifier_namespace": null, "stage_qualifier_category": null, "stage_qualifier_closure": [], "stage_qualifier_closure_label": []}, {"id": "uuid:5bce27eb-fd19-11ee-873f-57b99ea66a06", "category": "biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation", "subject": "CHEBI:17347", "original_subject": "MESH:D013739", "subject_namespace": "CHEBI", "subject_category": "biolink:MolecularEntity", "subject_closure": ["CHEBI:3992", "CHEBI:37577", "CHEBI:36838", "CHEBI:17347", "CHEBI:72695", "CHEBI:33285", "CHEBI:51958", "CHEBI:51689", "CHEBI:78840", "CHEBI:47788", "CHEBI:50860", "BFO:0000040", "CHEBI:25367", "CHEBI:51721", "CHEBI:36587", "CHEBI:36962", "CHEBI:36963", "CHEBI:23367", "CHEBI:35350", "BFO:0000001", "CHEBI:18059", "CHEBI:33304", "CHEBI:33582", "CHEBI:33608", "CHEBI:17087", "CHEBI:25806", "CHEBI:36586", "CHEBI:33674", "BFO:0000004", "CHEBI:35343", "CHEBI:33635", "CHEBI:24431", "CHEBI:35789", "CHEBI:36357", "CHEBI:131621", "CHEBI:33675", "CHEBI:33822", "BFO:0000002", "CHEBI:24651", "CHEBI:50402", "CHEBI:35341", "CHEBI:47909", "CHEBI:33595", "CHEBI:33832", "CHEBI:33579"], "subject_label": "testosterone", "subject_closure_label": ["organic oxo compound", "hydrogen molecular entity", "chemical entity", "androstanoid", "organic polycyclic compound", "s-block molecular entity", "independent continuant", "cyclic compound", "organic cyclic compound", "main group molecular entity", "olefinic compound", "3-oxo steroid", "organic molecular entity", "continuant", "hydroxides", "ketone", "lipid", "chalcogen molecular entity", "carbon group molecular entity", "organooxygen compound", "molecular entity", "hydroxy steroid", "oxygen molecular entity", "carbonyl compound", "testosterone", "organic molecule", "heteroorganic entity", "alpha,beta-unsaturated ketone", "C19-steroid", "p-block molecular entity", "organic hydroxy compound", "material entity", "steroid", "enone", "cyclic ketone", "heteroatomic molecular entity", "17-hydroxy steroid", "oxo steroid", "molecule", "3-oxo-Delta(4) steroid", "17beta-hydroxy steroid", "polycyclic compound", "organochalcogen compound", "polyatomic entity", "entity"], "subject_taxon": null, "subject_taxon_label": null, "predicate": "biolink:treats_or_applied_or_studied_to_treat", "object": "MONDO:0006732", "original_object": "MESH:D004409", "object_namespace": "MONDO", "object_category": "biolink:Disease", "object_closure": ["OGMS:0000031", "BFO:0000016", "BFO:0000001", "MONDO:0006732", "BFO:0000002", "MONDO:0005071", "BFO:0000017", "BFO:0000020", "MONDO:0700096", "MONDO:0000001"], "object_label": "drug-induced dyskinesia", "object_closure_label": ["disease", "drug-induced dyskinesia", "disposition", "nervous system disorder", "continuant", "disease", "specifically dependent continuant", "realizable entity", "human disease", "entity"], "object_taxon": null, "object_taxon_label": null, "primary_knowledge_source": "infores:ctd", "aggregator_knowledge_source": ["infores:monarchinitiative"], "negated": null, "pathway": null, "evidence_count": 1, "knowledge_level": "knowledge_assertion", "agent_type": "manual_agent", "has_evidence": [], "has_evidence_links": [], "has_count": null, "has_total": null, "has_percentage": null, "has_quotient": null, "grouping_key": "CHEBI:17347||biolink:treats_or_applied_or_studied_to_treat|MONDO:0006732", "provided_by": "ctd_chemical_to_disease_edges", "provided_by_link": {"id": "ctd_chemical_to_disease", "url": "https://monarch-initiative.github.io/monarch-ingest/Sources/ctd/#chemical_to_disease"}, "publications": ["PMID:28790"], "publications_links": [{"id": "PMID:28790", "url": "http://identifiers.org/pubmed/28790"}], "frequency_qualifier": null, "onset_qualifier": null, "sex_qualifier": null, "stage_qualifier": null, "qualifiers": [], "qualifiers_label": null, "qualifiers_namespace": null, "qualifiers_category": null, "qualifiers_closure": [], "qualifiers_closure_label": [], "qualifier": [], "qualifier_label": null, "qualifier_namespace": null, "qualifier_category": null, "qualifier_closure": [], "qualifier_closure_label": [], "frequency_qualifier_label": null, "frequency_qualifier_namespace": null, "frequency_qualifier_category": null, "frequency_qualifier_closure": [], "frequency_qualifier_closure_label": [], "onset_qualifier_label": null, "onset_qualifier_namespace": null, "onset_qualifier_category": null, "onset_qualifier_closure": [], "onset_qualifier_closure_label": [], "sex_qualifier_label": null, "sex_qualifier_namespace": null, "sex_qualifier_category": null, "sex_qualifier_closure": [], "sex_qualifier_closure_label": [], "stage_qualifier_label": null, "stage_qualifier_namespace": null, "stage_qualifier_category": null, "stage_qualifier_closure": [], "stage_qualifier_closure_label": []}, {"id": "uuid:5d84d189-fd19-11ee-873f-57b99ea66a06", "category": "biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation", "subject": "CHEBI:9948", "original_subject": "MESH:D014700", "subject_namespace": "CHEBI", "subject_category": "biolink:SmallMolecule", "subject_closure": ["CHEBI:60004", "CHEBI:60911", "CHEBI:9948", "BFO:0000040", "CHEBI:59999", "BFO:0000002", "BFO:0000004", "BFO:0000001", "CHEBI:24431"], "subject_label": "verapamil", "subject_closure_label": ["chemical entity", "independent continuant", "entity", "verapamil", "continuant", "material entity", "chemical substance", "mixture", "racemate"], "subject_taxon": null, "subject_taxon_label": null, "predicate": "biolink:treats_or_applied_or_studied_to_treat", "object": "MONDO:0006732", "original_object": "MESH:D004409", "object_namespace": "MONDO", "object_category": "biolink:Disease", "object_closure": ["OGMS:0000031", "BFO:0000016", "BFO:0000001", "MONDO:0006732", "BFO:0000002", "MONDO:0005071", "BFO:0000017", "BFO:0000020", "MONDO:0700096", "MONDO:0000001"], "object_label": "drug-induced dyskinesia", "object_closure_label": ["disease", "drug-induced dyskinesia", "disposition", "nervous system disorder", "continuant", "disease", "specifically dependent continuant", "realizable entity", "human disease", "entity"], "object_taxon": null, "object_taxon_label": null, "primary_knowledge_source": "infores:ctd", "aggregator_knowledge_source": ["infores:monarchinitiative"], "negated": null, "pathway": null, "evidence_count": 1, "knowledge_level": "knowledge_assertion", "agent_type": "manual_agent", "has_evidence": [], "has_evidence_links": [], "has_count": null, "has_total": null, "has_percentage": null, "has_quotient": null, "grouping_key": "CHEBI:9948||biolink:treats_or_applied_or_studied_to_treat|MONDO:0006732", "provided_by": "ctd_chemical_to_disease_edges", "provided_by_link": {"id": "ctd_chemical_to_disease", "url": "https://monarch-initiative.github.io/monarch-ingest/Sources/ctd/#chemical_to_disease"}, "publications": ["PMID:18363098"], "publications_links": [{"id": "PMID:18363098", "url": "http://identifiers.org/pubmed/18363098"}], "frequency_qualifier": null, "onset_qualifier": null, "sex_qualifier": null, "stage_qualifier": null, "qualifiers": [], "qualifiers_label": null, "qualifiers_namespace": null, "qualifiers_category": null, "qualifiers_closure": [], "qualifiers_closure_label": [], "qualifier": [], "qualifier_label": null, "qualifier_namespace": null, "qualifier_category": null, "qualifier_closure": [], "qualifier_closure_label": [], "frequency_qualifier_label": null, "frequency_qualifier_namespace": null, "frequency_qualifier_category": null, "frequency_qualifier_closure": [], "frequency_qualifier_closure_label": [], "onset_qualifier_label": null, "onset_qualifier_namespace": null, "onset_qualifier_category": null, "onset_qualifier_closure": [], "onset_qualifier_closure_label": [], "sex_qualifier_label": null, "sex_qualifier_namespace": null, "sex_qualifier_category": null, "sex_qualifier_closure": [], "sex_qualifier_closure_label": [], "stage_qualifier_label": null, "stage_qualifier_namespace": null, "stage_qualifier_category": null, "stage_qualifier_closure": [], "stage_qualifier_closure_label": []}]}